---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-091185"
form_type: "8-K"
ticker: "MD"
cik: "0000893949"
company_name: "Pediatrix Medical Group, Inc."
filed_at: "2024-08-06T23:59:59+00:00"
generated_at: "2026-05-31T12:51:21.294494+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Pediatrix Medical Group Q2 net loss $153M (-$1.84/share); Adjusted EPS $0.34 vs $0.39; CFO transition planned

## Summary
- Q2 net loss $153M ($1.84 loss per share) vs net income $28.3M ($0.34 EPS) in Q2 2023, driven by $192.9M impairment.
- Adjusted EPS fell to $0.34 from $0.39; Adjusted EBITDA $57.9M vs $59.1M. Revenue $504.3M (+0.7% YoY).
- Company exits office-based and primary/urgent care practices; expects ~$30M annualized EBITDA benefit; guidance reaffirmed $200-220M.
- CFO transition: Kasandra Rossi appointed to succeed Marc Richards effective ~Oct 1, 2024.
- Mary Ann Moore appointed CAO; Dr. Curtis Pickert transitions from COO to Chief Physician Executive (no longer exec officer).

## SEC filing metadata
- accession: 0000950170-24-091185
- form_type: 8-K
- ticker: MD
- cik: 0000893949
- company_name: Pediatrix Medical Group, Inc.
- filed_at: 2024-08-06T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/893949/000095017024091185/0000950170-24-091185-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/893949/000095017024091185/md-20240801.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-091185
- JSON: https://secwatch.observer/filing/0000950170-24-091185.json
- Plain text: https://secwatch.observer/filing/0000950170-24-091185.txt

## Key facts
- Executive change
  C. Marc Richards was terminated as Executive Vice President, Chief Financial Officer and Treasurer at Pediatrix Medical Group, Inc..
  - Action: terminated
  - Role: Executive Vice President, Chief Financial Officer and Treasurer
  source text: Mr. Richards’ transition from his role as Executive Vice President, CFO and Treasurer is a termination without “Cause” pursuant to that certain Amended and Restated Employment Agreement
  evidence_url: https://www.sec.gov/Archives/edgar/data/893949/000095017024091185/0000950170-24-091185-index.htm
- Executive change
  Kasandra Rossi was appointed as Executive Vice President, Chief Financial Officer and Treasurer at Pediatrix Medical Group, Inc..
  - Action: appointed
  - Role: Executive Vice President, Chief Financial Officer and Treasurer
  source text: On August 6, 2024, the Company announced that its board of directors (the “Board”) has appointed Ms. Kasandra Rossi, who currently serves as the Company’s Senior Vice President, Financial Reporting and Assistant Treasurer, to succeed Mr. C. Marc Richards as Executive Vice President, Chief Financial Officer (“CFO”) and Treasurer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/893949/000095017024091185/0000950170-24-091185-index.htm
- Executive change
  Curtis B. Pickert changed role as Executive Vice President, Chief Physician Executive at Pediatrix Medical Group, Inc..
  - Action: transitioned
  - Role: Executive Vice President, Chief Physician Executive
  source text: the Company announced that Curtis B. Pickert, M.D. has transitioned from his role as the Company’s Executive Vice President, Chief Operating Officer and will now serve as Pediatrix’s Executive Vice President, Chief Physician Executive, effective as of August 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/893949/000095017024091185/0000950170-24-091185-index.htm
- Executive change
  Mary Ann E. Moore was appointed as Chief Administrative Officer at Pediatrix Medical Group, Inc..
  - Action: appointed
  - Role: Chief Administrative Officer
  source text: The Company also announced that the Board has appointed Ms. Mary Ann E. Moore to serve as the Company’s Chief Administrative Officer, in addition to her existing roles as the Company’s Executive Vice President, General Counsel and Secretary, effective as of August 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/893949/000095017024091185/0000950170-24-091185-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.